Barrett Esophagus Clinical Trials

Find Barrett Esophagus Clinical Trials Near You

Endoscopic Management of Patients With High Risk T1a and T1b N0M0 Esophageal Adenocarcinoma: a Prospective Multicenter Registry.

Status: Recruiting
Location: See all (20) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Aim of this prospective multicenter study is to evaluate the safety of an endoscopic follow-up strategy in patients treated with endoscopic resection (ER) for submucosal or high-risk mucosal esophageal adenocarcinoma (T1bN0M0 or HR T1aN0M0 EAC).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with submucosal or high-risk mucosal EAC diagnosed in an ER specimen, by an expert gastrointestinal (GI) pathologists.

• Signed informed consent.

Locations
Other Locations
Australia
Westmead hospital
RECRUITING
Sydney
Belgium
CUB Hôpital Erasme
RECRUITING
Brussels
AZ Maria Middelares Ghent
RECRUITING
Ghent
UZ Leuven
RECRUITING
Leuven
AZ Delta Roeselare
RECRUITING
Roeselare
Germany
Universitätsklinikum Augsburg
RECRUITING
Augsburg
EVK Duesseldorf
RECRUITING
Düsseldorf
MRI TUM
ACTIVE_NOT_RECRUITING
Münich
Barmherzige Brüder Regensburg
RECRUITING
Regensburg
Netherlands
Amsterdam UMC
RECRUITING
Amsterdam
Catharina Hospital
RECRUITING
Eindhoven
University Medical Center Groningen
RECRUITING
Groningen
St. Antonius Hospital
RECRUITING
Nieuwegein
Radboudumc
RECRUITING
Nijmegen
Erasmus MC - University Medical Center
RECRUITING
Rotterdam
Haga Medical Center
RECRUITING
The Hague
Isala Clinics
RECRUITING
Zwolle
Switzerland
Hirslanden private hospital group
RECRUITING
Zurich
United Kingdom
University College London Hospital
RECRUITING
London
Nottingham University Hospitals NHS Trust
RECRUITING
Nottingham
Contact Information
Primary
Vincent Bos, MD
v.bos@amsterdamumc.nl
+31204445500
Time Frame
Start Date: 2017-07-25
Estimated Completion Date: 2028-07-25
Participants
Target number of participants: 225
Treatments
Experimental: Endoscopic follow-up
Patients treated with endoscopic resection (ER) for a submucosal or high-risk mucosal esophageal adenocarcinoma without lymphnode- or distant metastases (N0M0) will undergo endoscopic follow-up.
Related Therapeutic Areas
Sponsors
Leads: Amsterdam UMC

This content was sourced from clinicaltrials.gov